Ocugen, Inc. (OCGN)
NASDAQ: OCGN · Real-Time Price · USD
1.280
-0.090 (-6.57%)
At close: Jun 5, 2026, 4:00 PM EDT
1.330
+0.050 (3.90%)
After-hours: Jun 5, 2026, 7:56 PM EDT
Ocugen Market Cap
Ocugen has a market cap or net worth of $433.31 million as of June 5, 2026. Its market cap has increased by 83.18% in one year.
Market Cap
433.31M
Enterprise Value
434.75M
1-Year Change
83.18%
Ranking
Category
Stock Price
$1.28
Market Cap Chart
Since September 30, 2019, Ocugen's market cap has increased from $32.75M to $433.31M, an increase of 1,223.10%. That is a compound annual growth rate of 47.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 463.77M | 10.00% |
| Dec 31, 2025 | 421.63M | 79.79% |
| Dec 31, 2024 | 234.51M | 59.00% |
| Dec 29, 2023 | 147.49M | -48.17% |
| Dec 30, 2022 | 284.55M | -68.60% |
| Dec 31, 2021 | 906.30M | 205.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kyverna Therapeutics | 452.16M |
| 4D Molecular Therapeutics | 451.67M |
| Ovid Therapeutics | 447.94M |
| Rezolute | 443.98M |
| Sutro Biopharma | 432.32M |
| Contineum Therapeutics | 429.38M |
| C4 Therapeutics | 424.20M |
| Neurogene | 418.59M |